About Index Trending news
Analyze
Pricing
Syndax

Syndax

Work at Syndax? Add yourself to this profile

Syndax

Syndax Pharmaceuticals is a late-stage clinical development oncology company focused on overcoming the problem of resistance in cancer therapy.
Edit Profile
More info

Elsewhere

Companies in the same industry

AgeneBio AgeneBio Bioheart Bioheart Entelos Entelos Morphogen-IX Morphogen-IX LAM Therapeutics LAM Therapeutics Emerus Hospital Partners Emerus Hospital Partners GLO Science GLO Science InSite Vision InSite Vision Molplex Molplex Laurantis Pharma Laurantis Pharma

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 3
Add info
Latest funding Show all
Debt financing
$4,947,480
Venture capital (Series B)
$26,600,000
Domain Associates, MPM Capital, RusnanoMedInvest, +1
Employees

Team size

50+
Locations
Unknown
Help us complete this profile
Xconomy

East Coast Biotech Roundup: Ribon, Syndax, Aldeyra & More

Health Stock markets
Syndax
Syndax